Skip to main content

Davis Todd C

In the past year, 1 open-market purchase filing worth $999.8K and no sales.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
$999.8K
1 filing
Sold
–
0 filings
Net
+$999.8K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Davis Todd C as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

PTHS Pelthos Therapeutics Inc.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 15, 2026 (view filing)Jun 114 daysDavis Todd CDirectorPPurchase+35.9K$27.81+$999.8K+90.1%75.8K after2 lots

LGND Ligand Pharmaceuticals Inc

Chief Executive Officer3 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 13, 2025 (view filing)May 94 daysDavis Todd CChief Executive OfficerPPurchase+9.51K$105.20+$1.00M+6.3%161.2K after3 lots
Aug 9, 2024 (view filing)Aug 81 dayDavis Todd CChief Executive OfficerPPurchase+2.50K$97.39+$243.5K+2.1%123.0K after
Sep 25, 2023 (view filing)Sep 223 daysDavis Todd CCHIEF EXECUTIVE OFFICERPPurchase+4.00K$59.38+$237.5K+5.8%73.1K after